Back
Redcare Pharmacy NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Buy
52
SHPPF
Redcare Pharmacy NV
Last Price:
160.00
Seasonality Move:
53.36%
Sell
27
PRQR
ProQR Therapeutics NV
Last Price:
2.84
Seasonality Move:
2.19%
Buy
52
Redcare Pharmacy NV (SHPPF)
is a Buy
Is Redcare Pharmacy NV a Buy, Sell or Hold?
- The current Redcare Pharmacy NV [SHPPF] share price is $160.00. The Score for SHPPF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- SHPPF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $2.83. The Score for PRQR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- PRQR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SHPPF Stock Price Chart
What is Redcare Pharmacy NV's stock price today?
-
The Redcare Pharmacy NV share price today is $160.00
The current trend is moderately bearish and SHPPF is experiencing slight buying pressure.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $2.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
SHPPF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.08 | Buy |
| Relative Strength Index (14 RSI): | 70.9 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (160.84 - 161.28) | Sell |
| Bollinger Bands (100): | (120.78 - 155.32) | Buy |
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 32.39 | Sell |
| Chaikin Money Flow: | -707632 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.36 - 3.86) | Sell |
| Bollinger Bands (100): | (1.75 - 3.49) | Buy |
SHPPF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 160.97 | Sell |
| 20-day SMA: | 161.05 | Sell |
| 50-day SMA: | 151 | Buy |
| 200-day SMA: | 139.02 | Buy |
| 8-day EMA: | 160.85 | Sell |
| 20-day EMA: | 160.02 | Sell |
| 50-day EMA: | 152.6 | Buy |
| 200-day EMA: | 136.17 | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.35 | Sell |
| 20-day SMA: | 3.53 | Sell |
| 50-day SMA: | 3.32 | Sell |
| 200-day SMA: | 2.29 | Buy |
| 8-day EMA: | 3.3 | Sell |
| 20-day EMA: | 3.45 | Sell |
| 50-day EMA: | 3.24 | Sell |
| 200-day EMA: | 2.48 | Buy |
Redcare Pharmacy NV Earnings Growth & SHPPF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.07 per share.
Redcare Pharmacy NV Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProQR Therapeutics NV Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||